These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2666339)

  • 1. Short course chemotherapy for pulmonary tuberculosis. A randomised controlled trial of a six month versus a nine month oral regimen.
    Howell F; O'Laoide R; Kelly P; Power J; Clancy L
    Ir Med J; 1989 Feb; 82(1):11-3. PubMed ID: 2666339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
    Brändli O; Dreher D; Morger D
    Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
    Wada M
    Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
    Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W
    Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short term treatment of infantile pulmonary tuberculosis].
    Garciá López JR; Vidal López ML; Castán Vidal ML; Borque Andrés C; de José Gómez MI; García Hortelano J
    An Esp Pediatr; 1989 Aug; 31(2):110-3. PubMed ID: 2696390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of 3 6-month chemotherapy regimes in pulmonary tuberculosis in routine practice in Algiers. 18th-month results].
    Chaulet P; Boulahbal F; Ait Khaled N; El Awadi Z; Tazir M
    Rev Fr Mal Respir; 1983; 11(5):667-76. PubMed ID: 6658153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
    Mazouni L; Tazir M; Boulahbal F; Chaulet P
    Rev Mal Respir; 1985; 2(4):209-14. PubMed ID: 3937189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
    Balasubramanian R; Nagarajan M; Balambal R; Tripathy SP; Sundararaman R; Venkatesan P; Paramasivam CN; Rajasambandam P; Rangabashyam N; Prabhakar R
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):44-51. PubMed ID: 9441058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course drug therapy for tuberculosis.
    Stratton MA; Reed MT
    Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
    Punnotok J; Pumprueg U; Chakorn T
    J Med Assoc Thai; 1995 Jun; 78(6):298-304. PubMed ID: 7561554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.